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Alzheimer's disease (AD) is the most common cause of dementia in the elderly. This devastating brain disorder is characterized by progressive cognitive decline, where memory of recent facts, spatial orientation, attention and executive functions are ones of the first affected [1]. The pathological hallmarks of the disease are abnormal accumulations of extracellular amyloid plaques and intracellular neurofibrillary tangles (NFT) predominantly in the neocortex and hippocampus of AD patients. The main component of the plaques is ␤-amyloid (A␤), a 39-43 amino-acid long proteolytic product of the amyloid precursor protein (APP). A␤40 and A␤42 are the most common amyloid isoforms. Neurofibrillary tangles are composed mainly of paired helical filaments of a hyperphosphorylated form of the microtubule-associated protein tau. Other features of AD neuropathology include synaptic and neuronal loss, as well as inflammatory processes. Mutations in three genes, namely APP, presenilin 1 (PS1) and presenilin 2 (PS2), are responsible for up to one half of early onset cases of a hereditary form of AD
which shares the neuropathological characteristics of the more common, sporadic form of the disease. The mutations in these three proteins lead to altered production and secretion of A␤. Therefore, APP processing is considered to be a key event in AD pathogenesis [3] . Since the identification of AD-causing mutations, numerous transgenic mouse models recapitulating many features of the disease have been developed (reviewed in [4] ). These models have proven very valuable in dissecting the mechanisms involved in AD but there is still a need for a model better suited for more advanced studies, including serial cerebrospinal fluid sampling and complex behavioural testing. For these purposes, the rat offers several advantages over the mouse both due to its larger size and more complex behaviour repertoire [5] . However [18] . Structure volumes were estimated using stereological quantification based on Cavalieri's principle and point counting (reviewed in [19] 
Behavioural studies
There were no significant differences between the spontaneous locomotor activity of transgenic and control animals over the 60-min. open-field exposure in terms of the total distance moved (Fig. 1A) (Fig. 1B) . The analysis of behaviour during a shorter than 60 min. time interval is interesting since rats are most likely to explore the environment while it is novel to them, gradually reducing rearing as they become habituated to the surroundings [22] . (F [1, 11 ] ϭ 31.7, P Ͻ 0.0005)) (Fig. 2A) (Table 1) . Only the control rats preferentially swam in the pool quadrant where the platform was previously placed (Fig. 3) 
During the acquisition phase of the Morris water maze test (days 1-5) the Tg6590 rats spent significantly longer time trying to locate the platform as shown by a significant genotype effect on the escape latencies over time (ANOVA
)). On the last day of acquisition, after the last acquisition trial, the escape platform was removed and the animals were allowed to freely search the pool. During this probe trial, the Tg6590 rats performed significantly worse as determined by the analysis of five measures commonly used to assess memory for platform location/spatial memory: (i ) latency to reach the platform area, (ii ) frequency of platform crossings, (iii ) distance swam, (iv ) time spent and (v ) frequency of entries into the target zone
MRI volumetric analysis
Two months after completion of behavioural testing, at the age of 11 months, five animals from each group were investigated by MRI. Volumetric analysis of the resulting scans showed no statistically significant group differences between absolute volumes of brain, hippocampus or ventricles in the Tg6590 and control animals (Table 2). Interestingly, two out of five transgenic rats had greatly enlarged ventricles (37% and 53% larger than mean control value) and the difference increased to 58% and 77%, respectively, when normalized to the animal's brain volume. These two rats did not perform differently than the other transgenics in the behavioural tests. No hippocampal or cortical atrophy was seen in the transgenic animals of this age; however, preliminary data suggest enlargement of lateral ventricles and a thinning of the cortex in older Tg6590 animals as compared to controls (16 months old, data not shown). Since only a limited number of older animals have been analysed (three in each group) additional animals need to be investigated before any definite conclusions can be drawn.
APP expression and A␤ levels
The expression of human APP protein in the brains of all Tg6590 rats was confirmed in this study by Western blot of brain homogenates using the human-specific 6E10 antibody. Total A␤ levels (rat and human) were measured in the 10 rats used in the behavioural study at 9 months of age and later imaged by MRI at 11 months of age. The Tg6590 rats had significantly higher levels of soluble A␤40 and A␤42 both in the hippocampus and the cortex, as compared to controls (Fig. 4) . The hippocampal levels of A␤40 and A␤42 were increased by 67% and 65%, respectively, in the transgenic animals (P Ͻ 0.01), whereas cortical A␤ levels were elevated by 44% and 40%, respectively (P Ͻ 0.01). There were no differences in A␤42/A␤40 ratios between the animal groups. This was expected since the APPswe mutation affects ␤-secretase processing of APP resulting in an increase in both A␤40 and A␤42 [23] . 
Analysis of phosphorylation, synaptic and neuronal markers
We have previously reported an apparent increase in the phosphorylation of tau in old Tg6590 animals as detected by the PHF-1 antibody [13] 
Discussion
Many transgenic mouse models of AD show behavioural impairments that are attributed to perturbations in components of the amyloid-processing pathway. The transgenic rat lines available so far show lower expression levels of the APP transgene than mouse AD models and only mild or no A␤ deposition in the brain. The only exception is the triple-transgenic homozygous rat carrying two mutant APP constructs and one mutated PS1, which shows extensive extracellular amyloid deposits [12] . This rat line has however been shown to be prone to premature death due to such health problems as chronic kidney disease, hypertension and immunosuppression [24] , which sets limitations on its use as an AD research model.
Recently more attention has been focused on the effects of soluble forms of A␤ oligomers on cognition, as it has been
shown that there is no simple correlation between plaque load in AD and dementia [25] [26] . Long-term effects of A␤42 immunization in AD patients showed, in seven of eight immunized patients, at post mortem investigation that although plaques were removed the patients had no improved survival and they all progressed to severe dementia. This indicates that removal of plaques is not sufficient to prevent progression of the clinical symptoms [27] . [33] . It is also well known that AD patients may have striking fluctuations in functional abilities even within the same day, which strongly implies that at least some of the neurological impairment is due to a dysfunction of neuronal networks rather than loss of neurons [34] . We have previously shown that primary neurons derived from the Tg6590 rats have increased intracellular calcium levels and altered calcium signalling which is indicative of aberrant neuronal activation [35] [36] 
